High grade serous ovarian carcinomas originate in the fallopian tube
By S. Labidi-Galy, E. Papp, Dorothy Hallberg, N. Niknafs, V. Adleff, Michael Noe, Rohit Bhattacharya, M. Novak, Siân Jones, J. Phallen and 16 more. Nature Communications, 2017
662 citations recorded by the source corpus.
High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian cancer and has a poor outcome. It has been proposed that fallopian tube cancers may be precursors of HGSOC but evolutionary evidence for this hypothesis has been limited. Here, we perform whole-exome sequence and copy number analyses of laser capture microdissected fallopian tube lesions (p53 signatures, serous tubal intraepithelial carcinomas (STICs), and fallopian tube carcinomas), ovarian cancers, and metastases from nine patients. The majority of tumor-specific alterations in ovarian cancers were present in STICs, including those affecting TP53, BRCA1, BRCA2 or PTEN. Evolutionary analyses reveal that p53 signatures and STICs are precursors of ovarian carcinoma and identify a window of 7 years between development of a STIC and initiation of ovarian carcinoma, with metastases following rapidly thereafter. Our results provide insights into the etiology of ovarian cancer and have implications for prevention, early detection and therapeutic intervention of this disease. It has previously been proposed that high-grade serous ovarian carcinoma (HGSOC) may originate from the fallopian tube. Here, the authors analyze genetic aberrances in fallopian tube lesions, ovarian cancers, and metastases from HGSOC patients and establish the evolutionary origins of HGSOC in the fallopian tube.
Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/b491df3d0b6c859c6170c9c1a949e044cc7fce0e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Reproductive Medicine
Citations in the corpus
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease (2019, background): “Level of evidence: V Strength of recommendation: B Consensus: 92.5% (37) yes, 2.5% (1) no, 5% (2) abstain (40 voters) Recommendation 6.5: peritoneal restaging should be considered in cases of incidentally detected, apparently isolated STIC lesions.”
- ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. (2019, background): “and copy abnormalities seen in HGSC are also identified in accompanying STIC.(13) Clonal evolution studies demonstrate the same result(14) 15 but also show that, in advanced cases, intraepithelial tubal”